Ritesh P. Daya

Most-cited papers

1. Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders

   Y. El-Hayek, R. E. Wiley, C. P. Khoury, Ritesh P. Daya +6 more

   2019Journal of Alzheimer's Disease200 citations Open access

   Semantic Scholar

   Save

2. Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.

   Y. Katare, Ritesh P. Daya, Christal Sookram Gray, Roger E. Luckham +3 more

   2015Molecular Pharmaceutics95 citations Open access

   Semantic Scholar

   Save

3. Intranasal delivery of antipsychotic drugs.

   Y. Katare, Justin E. Piazza, J. Bhandari, Ritesh P. Daya +4 more

   2017Schizophrenia Research49 citations

   Semantic Scholar

   Save

4. PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.

   Michael G R Beyaert, Ritesh P. Daya, Bailey A. Dyck, Rodney L. Johnson +1 more

   2013European Neuropsychopharmacology28 citations

   Semantic Scholar

   Save

5. Synapsin II Gene Expression in the Dorsolateral Prefrontal Cortex of Brain Specimens from Patients with Schizophrenia and Bipolar Disorder: Effect of Lifetime Intake of Antipsychotic Drugs

   M. Tan, Bailey A. Dyck, Joseph P. Gabriele, Ritesh P. Daya +6 more

   2013The Pharmacogenomics Journal25 citations Open access

   Semantic Scholar

   Save

6. Curcumin prevents haloperidol‐induced development of abnormal oro‐facial movements: Possible implications of Bcl‐XL in its mechanism of action

   Christal D. Sookram, M. Tan, Ritesh P. Daya, Spencer Heffernan +1 more

   2011Synapse19 citations

   Semantic Scholar

   Save

7. Improvements and important considerations for the 5-choice serial reaction time task-An effective measurement of visual attention in rats.

   J. Bhandari, Ritesh P. Daya, R. Mishra

   2016Journal of Neuroscience Methods16 citations

   Semantic Scholar

   Save

8. Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats.

   Ritesh P. Daya, J. Bhandari, Patricia Hui, Yuxin Tian +2 more

   2014Neuropharmacology13 citations

   Semantic Scholar

   Save

9. Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.

   Bailey A. Dyck, M. Tan, Ritesh P. Daya, Dipannita Basu +3 more

   2012Schizophrenia Research13 citations

   Semantic Scholar

   Save

10. The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia

    Ritesh P. Daya, J. Bhandari, Sharnpreet K. Kooner, Joella Ho +4 more

    2018Frontiers in Behavioral Neuroscience11 citations Open access

    Semantic Scholar

    Save

11. Transformation of Pro-Leu-Gly-NH2 peptidomimetic positive allosteric modulators of the dopamine D2 receptor into negative modulators.

    Swapna Bhagwanth, Satyendra Mishra, Ritesh P. Daya, J. Mah +2 more

    2012ACS Chemical Neuroscience11 citations Open access

    Semantic Scholar

    Save

12. Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes.

    Ritesh P. Daya, M. Tan, Christal D. Sookram, K. Skoblenick +1 more

    2011Brain Research11 citations

    Semantic Scholar

    Save

13. Effect of Chronic Treatment with D2 Allosteric Modulator PAOPA on the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) in Select Brain Regions

    Yuxin Tian, Ritesh P. Daya, J. Bhandari, Hetshree Joshi +3 more

    2021International Journal of Peptide Research and Therapeutics1 citations

    Semantic Scholar

    Save

14. The Effect of PAOPA, a Novel Allosteric Modulator of Dopamine D2 Receptors, on Select Signaling Proteins Following Sub-Chronic Administration in the Rat.

    Ritesh P. Daya, Joella Ho, S. Thomson, J. Bhandari +1 more

    2020Current Molecular Pharmacology1 citations

    Semantic Scholar

    Save

15. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia

    S. Thomson, Bailey A. Dyck, Ritesh P. Daya, Joella Ho +3 more

    2019Synapse1 citations

    Semantic Scholar

    Save

16. The Investigation and Development of Novel Molecules, Models and Tools for the Treatment and Study of Schizophrenia

    Ritesh P. Daya

    20170 citations

    Semantic Scholar

    Save

17. Cell-Free Protein Synthesis and Purification of the Dopamine D2 Receptor

    Dipannita Basu, Ritesh P. Daya, Christal D. Sookram, R. Mishra

    20150 citations

    Semantic Scholar

    Save

18. Compound 186 is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy

    J. Bhandari, J. Mah, Ritesh P. Daya, Rodney L. Johnson +1 more

    2013The Meducator0 citations Open access

    Semantic Scholar

    Save

19. Effect of Neurofibrillary Tangles on Behavioural Flexibility in Rats: Animal Models for Fronto-Temporal Dementia and Alzheimer’s Disease

    J. Bhandari, J. Mah, Ritesh P. Daya, R. L. +5 more

    20130 citations

    Semantic Scholar

    Save

20. Allosteric Modulators: Potential Treatment for Schizophrenia

    Ritesh P. Daya

    20120 citations

    Semantic Scholar

    Save

21. Catecholamine Regulated Protein (CRP40), A Splice Variant of Mortalin-2: Functional Role in CNS Disorders

    Joseph P. Gabriele, Sarah E. Groleau, Ritesh P. Daya, Z. Pristupa +1 more

    20120 citations

    Semantic Scholar

    Save